Mohit Bhandari, MD, answers our questions about the HEALTH trial, which investigated the effect of a total hip arthroplasty compared with hemiarthroplasty among patients with femoral neck fracture.
Lead author Lihi Eder, MD, PhD, answers our questions about her study that evaluated musculoskeletal issues preceding patients’ diagnosis of psoriatic arthritis. This period may represent a window for...
Peter Mandl, MD, PhD, answers our questions about his research that shed light on the advantages and disadvantages of implementing imaging techniques into a treat-to-target approach in psoriatic arthritis...
Marita Cross, PhD, from the Institute of Bone and Joint Research at the University of Sydney, answers our questions about her research on the global burden of rheumatoid arthritis.
In this Q&A, Dr Machado answers our questions about the impact that biologic disease-modifying antirheumatic drugs have in axial spondyloarthritis remission.
Transferring a patient with a rheumatic condition from pediatric care to adult care comes with challenges. In this Q&A, Nicole Bitencourt, MD, highlights strategies that you can use to ensure that the...
Clifford Rosen, MD, chair of the Endocrine Society's 2019 clinical practice guideline for the pharmacological management of osteoporosis in postmenopausal women, reviews key points of the new...
Robyn Wiesel, MCHES, from Hospital for Special Surgery, answers our questions about the importance of self-management education programs for patients with rheumatic diseases and other chronic conditions.
...
Anniek M. van Roon, MD, PhD, answered our questions about the efficacy and feasibility of single-port thoracoscopic sympathicotomy among patients with treatment-resistant Raynaud phenomenon.
Yun Gao, MD, and Xiang Gao, MD, PhD, answer our questions about their research on the impact of the DASH diet on hyperuricemia in patients without gout.
